{"id":"https://openalex.org/W37092178","doi":null,"title":"Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors.","display_name":"Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors.","publication_year":2004,"publication_date":"2004-06-01","ids":{"openalex":"https://openalex.org/W37092178","mag":"37092178","pmid":"https://pubmed.ncbi.nlm.nih.gov/15243410"},"language":"en","primary_location":{"id":"pmid:15243410","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15243410","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054372316","display_name":"Emilio Bombardieri","orcid":"https://orcid.org/0000-0003-4063-8167","observed_orcids":["https://orcid.org/0000-0003-4063-8167"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"E Bombardieri","raw_affiliation_strings":["Nuclear Medicine Division, Istituto Nazionale Tumori, Milan, Italy. bombardieri@istitutotumori.mi.it","Nuclear Medicine Division, Istituto Nazionale Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuclear Medicine Division, Istituto Nazionale Tumori, Milan, Italy. bombardieri@istitutotumori.mi.it","institution_ids":["https://openalex.org/I4210156707"]},{"raw_affiliation_string":"Nuclear Medicine Division, Istituto Nazionale Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088022548","display_name":"Ettore Cesare Seregni","orcid":"https://orcid.org/0000-0002-5097-049X","observed_orcids":["https://orcid.org/0000-0002-5097-049X"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"E Seregni","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088974025","display_name":"Carlo Villano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Villano","raw_affiliation_strings":["Istituto Nazionale Ricerca Cancer, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Ricerca Cancer, Milan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089626999","display_name":"Arturo Chiti","orcid":"https://orcid.org/0000-0002-5806-1856","observed_orcids":["https://orcid.org/0000-0002-5806-1856"]},"institutions":[{"id":"https://openalex.org/I4210163047","display_name":"IRCCS Humanitas Research Hospital","ror":"https://ror.org/05d538656","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210163047"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A Chiti","raw_affiliation_strings":["Istituto Clinico Humanitas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Clinico Humanitas","institution_ids":["https://openalex.org/I4210163047"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070704228","display_name":"Emilio Bajetta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Bajetta","raw_affiliation_strings":["Istituto Nazionale Ricerca Cancer, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Ricerca Cancer, Milan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.492,"has_fulltext":false,"cited_by_count":56,"citation_normalized_percentile":{"value":0.92142981,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"48","issue":"2","first_page":"150","last_page":"63"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuroendocrine-tumors","display_name":"neuroendocrine tumors","score":1.0},{"id":"https://openalex.org/keywords/nuclear-medicine","display_name":"nuclear medicine","score":0.7229999899864197},{"id":"https://openalex.org/keywords/somatostatin-receptor-scintigraphy","display_name":"somatostatin receptor scintigraphy","score":0.859000027179718},{"id":"https://openalex.org/keywords/metaiodobenzylguanidine","display_name":"metaiodobenzylguanidine","score":0.824999988079071},{"id":"https://openalex.org/keywords/octreotide","display_name":"octreotide","score":0.7639999985694885},{"id":"https://openalex.org/keywords/somatostatin-analogs","display_name":"somatostatin analogues","score":0.800000011920929},{"id":"https://openalex.org/keywords/positron-emission-tomography","display_name":"positron emission tomography","score":0.843999981880188},{"id":"https://openalex.org/keywords/fdg-pet","display_name":"FDG-PET","score":0.7120000123977661},{"id":"https://openalex.org/keywords/radiopharmaceuticals","display_name":"radiopharmaceuticals","score":0.7960000038146973},{"id":"https://openalex.org/keywords/tumor-staging","display_name":"tumor staging","score":0.5789999961853027},{"id":"https://openalex.org/keywords/restaging","display_name":"restaging","score":0.6759999990463257},{"id":"https://openalex.org/keywords/treatment-monitoring","display_name":"treatment monitoring","score":0.7990000247955322},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7590000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8688075542449951},{"id":"https://openalex.org/C2779066768","wikidata":"https://www.wikidata.org/wiki/Q1981276","display_name":"Neuroendocrine tumors","level":2,"score":0.7972972393035889},{"id":"https://openalex.org/C2993559085","wikidata":"https://www.wikidata.org/wiki/Q2126444","display_name":"Radionuclide therapy","level":2,"score":0.5671557784080505},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.4904131591320038},{"id":"https://openalex.org/C2994052390","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine imaging","level":2,"score":0.4536364674568176},{"id":"https://openalex.org/C80115893","wikidata":"https://www.wikidata.org/wiki/Q2067077","display_name":"Somatostatin receptor","level":3,"score":0.43279483914375305},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.4236019253730774},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.4200347065925598},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.3940991759300232},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2633382976055145},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24891844391822815},{"id":"https://openalex.org/C2776297358","wikidata":"https://www.wikidata.org/wiki/Q407166","display_name":"Somatostatin","level":2,"score":0.23532935976982117}],"mesh":[{"descriptor_ui":"D000310","descriptor_name":"Adrenal Gland Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D005770","descriptor_name":"Gastrointestinal Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D010911","descriptor_name":"Pituitary Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D011877","descriptor_name":"Radionuclide Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013964","descriptor_name":"Thyroid Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D018278","descriptor_name":"Carcinoma, Neuroendocrine","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D018813","descriptor_name":"Multiple Endocrine Neoplasia Type 2a","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15243410","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15243410","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...","raw_type":"Journal Article"},{"id":"mag:37092178","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15243410","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W284344445","https://openalex.org/W1992840915","https://openalex.org/W2000280911","https://openalex.org/W2010101647","https://openalex.org/W2020148757","https://openalex.org/W2050068708","https://openalex.org/W2062068716","https://openalex.org/W2151524246","https://openalex.org/W2321593984","https://openalex.org/W2345405062","https://openalex.org/W2345654247","https://openalex.org/W2414404462","https://openalex.org/W2518536270","https://openalex.org/W2529875271","https://openalex.org/W2554060857","https://openalex.org/W2597483887","https://openalex.org/W2609522512","https://openalex.org/W2611596865","https://openalex.org/W2693237708","https://openalex.org/W2734827844","https://openalex.org/W2884339844","https://openalex.org/W2891542714","https://openalex.org/W2899173353","https://openalex.org/W2900499085","https://openalex.org/W2917401353","https://openalex.org/W2969494284","https://openalex.org/W2995070274","https://openalex.org/W3002052337","https://openalex.org/W3009920944","https://openalex.org/W3023662906","https://openalex.org/W3032007913","https://openalex.org/W3033673807","https://openalex.org/W3038518616","https://openalex.org/W3047692533","https://openalex.org/W3084118349","https://openalex.org/W3091956488","https://openalex.org/W3124639756","https://openalex.org/W3195790693","https://openalex.org/W3197386731","https://openalex.org/W3205723203","https://openalex.org/W4308101908"],"related_works":["https://openalex.org/W2417073673","https://openalex.org/W2106067878","https://openalex.org/W2168147909","https://openalex.org/W1531076604","https://openalex.org/W2052520415","https://openalex.org/W189728629","https://openalex.org/W3022610197","https://openalex.org/W2583211791","https://openalex.org/W2080569250","https://openalex.org/W4235009248"],"abstract_inverted_index":{"In":[0,141,272],"recent":[1],"years":[2],"nuclear":[3,51,57,98,195,236],"medicine":[4,52,58,99,196,237],"has":[5,183],"contributed":[6],"to":[7,37,132,143,171,184,242,250,304],"the":[8,12,39,63,77,87,92,109,136,144,178,246,251,274,287,302],"impressive":[9],"development":[10],"of":[11,14,19,25,41,56,65,76,95,111,129,138,157,180,201,253,277,289,301],"knowledge":[13],"neuroendocrine":[15,47,181,202,278],"tumors":[16,182,203],"in":[17,150,262],"terms":[18],"biology":[20],"(receptor":[21,280],"scintigraphy),":[22],"pharmacology":[23],"(development":[24],"new":[26,116],"tracers),":[27],"and":[28,61,80,86,97,105,166,265,269,296],"therapy":[29],"(radiometabolic":[30],"therapy).":[31],"At":[32,233],"present,":[33],"it":[34],"is":[35,204],"impossible":[36],"plan":[38],"management":[40,64],"a":[42,46,127,155,173,260,293,299],"patient":[43,267],"affected":[44,60],"by":[45,68,220],"tumor":[48,139],"without":[49],"performing":[50],"examinations.":[53],"The":[54,83,198],"contribution":[55],"had":[59],"improved":[62],"these":[66],"patients":[67],"offering":[69],"various":[70],"important":[71],"options":[72],"that":[73],"are":[74,108,119,169,239],"part":[75],"modern":[78],"diagnosis":[79,179,248],"treatment":[81,270],"protocols.":[82],"clinical":[84,113,174,199,247],"experience":[85],"literature":[88],"confirm":[89],"that,":[90],"among":[91],"wide":[93],"variety":[94],"tracers":[96],"modalities":[100,238],"available":[101],"today,":[102],"metaiodobenzylguanidine":[103],"(MIBG)":[104],"DTPA-D-Phe-octreotide":[106],"(pentetreotide)":[107],"radiopharmaceuticals":[110,158],"current":[112],"use.":[114],"Several":[115],"somatostatin":[117],"analogues":[118],"under":[120],"investigation.":[121],"Positron":[122],"emission":[123],"tomography":[124],"(PET)":[125],"supplies":[126],"range":[128],"labelled":[130],"compounds":[131],"be":[133,185,218],"used":[134,147],"for":[135,230],"visualization":[137],"biochemistry.":[140],"addition":[142],"first":[145],"routinely":[146],"PET":[148],"tracer":[149],"oncology,":[151],"18F-labelled":[152],"deoxyglucose":[153],"(FDG),":[154],"number":[156],"based":[159,186],"on":[160,187],"different":[161,192],"precursors":[162],"such":[163],"as":[164,292,298],"fluorodopamine":[165],"5-hydroxytryptophan":[167],"(5-HTP)":[168],"going":[170],"gain":[172],"role.":[175],"Of":[176],"course,":[177],"integrated":[188],"information":[189],"derived":[190],"from":[191],"examinations":[193],"including":[194],"studies.":[197],"presentation":[200,235],"highly":[205],"variable:":[206],"sometimes":[207,240,297],"they":[208,215],"manifest":[209],"typical":[210],"or":[211,225],"atypical":[212],"symptoms":[213],"but":[214],"may":[216],"also":[217,258],"detected":[219],"chance":[221],"during":[222],"an":[223],"X-ray":[224],"ultrasound":[226],"examination":[227],"carried":[228],"out":[229],"other":[231],"reasons.":[232],"disease":[234,263],"able":[241],"direct":[243],"physicians":[244],"towards":[245],"thanks":[249],"specificity":[252],"their":[254],"imaging":[255],"mechanisms.":[256],"They":[257],"play":[259],"role":[261],"staging":[264],"restaging,":[266],"follow-up":[268],"monitoring.":[271],"addition,":[273],"biological":[275],"characterisation":[276],"tissues":[279],"status,":[281],"glucose":[282],"metabolism,":[283],"differentiation,":[284],"etc.)":[285],"allows":[286],"interpretation":[288],"radiopharmaceutical":[290],"uptake":[291],"prognostic":[294],"parameter":[295],"predictor":[300],"response":[303],"treatment.":[305]},"counts_by_year":[{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}